Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
:ELMD
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
0.2Last Year’s EPS
0.17Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 11, 2025
|% Change Since: -4.21%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with record revenues, growth in multiple segments, and efficient financial management. While there were some increases in expenses and minor fluctuations in revenue, the overall outlook remains positive with continued growth and strategic investments.Company Guidance
During the Electromed Second Quarter 2025 Earnings Conference Call, the company reported record revenues of $16.3 million, marking the ninth consecutive quarter of year-over-year growth. Operating income reached a record $2.5 million, while net income was $2 million, or $0.22 per diluted share. The Hospital segment grew by 17%, and durable medical equipment distributor relationships saw a 188% increase in revenue. The company reduced inventory by 35% compared to Q2 of fiscal 2024, while maintaining patient therapy needs. They ended the quarter with 54 direct sales representatives, aiming for 57 by the end of Q3. Electromed also initiated a new CRM system investment to boost productivity and internal collaboration. Overall, they achieved a gross profit of $12.6 million, representing 77.7% of net revenues, and maintained a strong cash position of $16.2 million with no debt.Record Revenues and Growth
Electromed reported record revenues of $16.3 million, marking the ninth consecutive quarter of year-over-year growth in revenue and net income. Operating income reached a record $2.5 million, while net income was $2 million or $0.22 per fully diluted share.
Diverse Segment Growth
The Hospital segment grew by 17%, and durable medical equipment distributor relationships saw year-over-year growth of 188%, reflecting strong demand.
Sales Team Expansion and Efficiency
The company increased its sales team to 54 direct sales reps, aiming for 57 by the end of Q3 FY 2025. Investments in a new CRM system are expected to enhance productivity.
Improved Financial Metrics
Gross profit increased to $12.6 million, or 77.7% of net revenues. SG&A expenses increased due to compensation costs and higher personnel numbers, but operating income still reached a record high.
Strong Cash Position
Electromed reported a cash balance of $16.2 million with no debt, achieving a working capital of $35.5 million and total shareholders' equity of $43.6 million.
---
ELMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ELMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 11, 2025 | $29.20 | $33.28 | +13.97% |
| Nov 12, 2024 | $26.44 | $27.79 | +5.11% |
| Aug 27, 2024 | $16.05 | $15.00 | -6.54% |
| May 07, 2024 | $17.51 | $17.08 | -2.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Electromed (ELMD) report earnings?
Electromed (ELMD) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Electromed (ELMD) earnings time?
Electromed (ELMD) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ELMD EPS forecast?
ELMD EPS forecast for the fiscal quarter 2025 (Q3) is 0.2.
---